Background: Loss of function of the parkin gene (PRKN) is the predominant genetic cause of juvenile and earlyonset parkinsonism in Japan, Europe, and the United States. Objectives: To evaluate the frequency of PRKN mutations in Taiwanese (ethnic Chinese) patients with earlyonset parkinsonism and to explore genotypephenotype correlations. Design: Clinical assessment included medical, neurologic, and psychiatric evaluation. GenomicDNAsequencing and quantitative polymerase chain reaction were performed to identify PRKN mutations. Gene expression was examined in patient lymphoblastoid cell lines, in which PRKN mutations were identified. Patients: Forty-one Taiwanese patients with earlyonset parkinsonism (aged Results: Four of 41 probands had PR...
Objective: Mutations in the parkin (PARK2) gene have been associated with autosomal recessive early-...
Objective: Mutations in the parkin (PARK2) gene have been associated with autosomal recessive early-...
Approximately 3.6% of patients with Parkinson's disease develop symptoms before age 45. Early-onset ...
We screened for mutations in the PARKIN, DJ-1, and PINK1 genes in a Taiwanese cohort (68 probands; 5...
Mutations in five PARK genes (SNCA, PARKIN, DJ-1, PINK1, and LRRK2) are well-established genetic cau...
IntroductionGenetic mutations associated with early-onset Parkinson's disease (EOPD) vary widely amo...
parkin mutations are the most common identified cause of Parkinson's disease (PD). It has been sugge...
A multiethnic series of patients with early-onset Parkinson's disease (EOP) was studied to assess th...
We analysed the parkin gene in a large consecutive series (146) of unrelated early onset Parkinson's...
OBJECTIVE: To establish phenotype-genotype correlations in early-onset Parkinson disease (EOPD), we ...
The aim of the study is to determine the frequency of parkin allelic variants in Czech early-onset P...
Abstract Our aim was to characterise PARK2 mutations and clinical features in Hong Kong Chinese with...
Our objective was to define the prevalence and clinical features of genetic Parkinson's disease in a...
Recently, mutations in DJ-1 (PARK7) were described as a novel cause of early-onset parkinsonism. We ...
[[abstract]]Parkinson’s disease (PD) is the second most common neurodegenerative disorder characteri...
Objective: Mutations in the parkin (PARK2) gene have been associated with autosomal recessive early-...
Objective: Mutations in the parkin (PARK2) gene have been associated with autosomal recessive early-...
Approximately 3.6% of patients with Parkinson's disease develop symptoms before age 45. Early-onset ...
We screened for mutations in the PARKIN, DJ-1, and PINK1 genes in a Taiwanese cohort (68 probands; 5...
Mutations in five PARK genes (SNCA, PARKIN, DJ-1, PINK1, and LRRK2) are well-established genetic cau...
IntroductionGenetic mutations associated with early-onset Parkinson's disease (EOPD) vary widely amo...
parkin mutations are the most common identified cause of Parkinson's disease (PD). It has been sugge...
A multiethnic series of patients with early-onset Parkinson's disease (EOP) was studied to assess th...
We analysed the parkin gene in a large consecutive series (146) of unrelated early onset Parkinson's...
OBJECTIVE: To establish phenotype-genotype correlations in early-onset Parkinson disease (EOPD), we ...
The aim of the study is to determine the frequency of parkin allelic variants in Czech early-onset P...
Abstract Our aim was to characterise PARK2 mutations and clinical features in Hong Kong Chinese with...
Our objective was to define the prevalence and clinical features of genetic Parkinson's disease in a...
Recently, mutations in DJ-1 (PARK7) were described as a novel cause of early-onset parkinsonism. We ...
[[abstract]]Parkinson’s disease (PD) is the second most common neurodegenerative disorder characteri...
Objective: Mutations in the parkin (PARK2) gene have been associated with autosomal recessive early-...
Objective: Mutations in the parkin (PARK2) gene have been associated with autosomal recessive early-...
Approximately 3.6% of patients with Parkinson's disease develop symptoms before age 45. Early-onset ...